A carregar...

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis

Rituximab (RTM), a monoclonal antibody against CD20+ receptors on the membrane of B-cells, is becoming increasingly important for the induction and maintenance treatment of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (ANCA-SV). The challenge facing us is to optimize its...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: T. V. Beketova, E. L. Nasonov
Formato: Artigo
Idioma:Russo
Publicado em: IMA-PRESS LLC 2020-03-01
Colecção:Современная ревматология
Assuntos:
Acesso em linha:https://mrj.ima-press.net/mrj/article/view/987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!